This study is monitoring 11 people who previously received an experimental gene therapy for HIV. The goal is to check for any long-term safety issues that might appear years after their treatment. Researchers are watching the patients' health and tracking the modified cells in th…
Sponsor: Calimmune, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC